News & Events | Shonan iPark

=================================

News (Past Years)

[2022.09.28]

【Press Release】Shonan iPark Announces Finalists of its Second Incubation Program: “Japan Innovation Bloom GRANT CALL 2022”

[2022.07.13]

【Media Coverage】Toshio Fujimoto, General Manager of Shonan iPark, was interviewed by Sankei Newspaper regarding the creation of an effective drug discovery ecosystem in Japan “Reviving the Pharmaceutical Industry: Overcoming Vaccine Defeat”

[2022.05.13]

【Press Release】Shonan iPark Collaborates with Johnson & Johnson Innovation, Janssen Research & Development, LLC, and Takeda Pharmaceutical Company Limited to Launch Japan Innovation Bloom GRANT CALL 2022

[2021.03.24]

【Press Release】Shonan iPark Signs Memorandum of Understanding for Strategic Alliance with Chinese Science Park ‘Suzhou Industrial Park’

[2021.12.01]

【Press Release】ARTham Therapeutics, Inc. Enters into Share Transfer Agreement with Kaken Pharmaceutical Co., Ltd.

[2021.08.10]

【Tenant's News】New company "Orizuru Therapeutics Inc." launched from T-CiRA in Shonan iPark.

[2021.06.22]

【Press Release】iPark Invites Companies to Join Second Phase of “Japan VC Consortium,”a Platform Driving VC, CVC, and Pharmaceutical Company Collaboration

[2021.04.21]

【Press Release】Muraoka-Fukasawa District Transforms into Cutting-Edge Center for Health Innovation

[2021.04.15]

【Press Release】New Pathway Launched for Pioneering Life Science Companies Seeking Japanese Market Entry

[2021.04.06]

【Press Release】Shonan iPark Signs Partnership Agreement with UK Science Ecosystem, via the National Horizons Centre

[2021.02.02]

【Press Release】Shonan iPark Initiates Pilot Program for Development of iPS Cell Delivery Platform

[2021.01.21]

【Event Report】The summary report of the online event "Innovation and sustainability in Japan’s healthcare system", held on November 25 hosted by The Economist, in which iPark General Manager Fujimoto participated, is now available for download.

Click here to read the white paper "Supporting an Innovative Life Science Ecosystem in Japan" published by The Economist.
*General Manager Fujimoto cooperated in the interview as an expert.

Shonan iPark hosted a panel discussion at BIO Digital 2020

Shonan iPark Introduction Movie

Presentation by Toshio Fujimoto

Session 1

What are the common traits of global innovation ecosystems?

Session 2

What are the current challenges and opportunities amid COVID-19?

Session 3

What is the new normal for innovation ecosystems?

News Archives (Takeda Pharmaceutical Shonan Research Center)

This page contains past news from Takeda Pharmaceutical Shonan Research Center, the predecessor of Shonan iPark. (in Japanese)

Copyright © Shonan Health Innovation Park. All rights reserved.